Wound Care Market - Product (Advanced Wound Dressing, Surgical Wound Care, Traditional Wound Care, Wound Therapy Devices, Wound Care Biologics), Application (Chronic, Acute), End use – Global Forecast, 2023-2032

Wound Care Market Size

Wound Care Market size was valued at USD 21.2 billion in 2022 and is estimated to witness 5.9% CAGR from 2023 to 2032. Wound care dressings refer to material that is applied directly to a wound to facilitate the healing process and protect the injured area. The increasing incidence of burn injuries is one of the major factors driving the demand for wound care dressings.
 

For instance, according to the WHO, an estimated 180,000 deaths occur annually due to burns, with the majority of these deaths occurring in low- and middle-income countries. Furthermore, the growing prevalence of diabetes worldwide is a significant factor contributing to delayed wound healing. Moreover, about 15-25% of people with diabetes will develop a foot ulcer at some point in their lives, and these ulcers can be challenging to heal. Diabetic foot ulcers and pressure ulcers are a common complication and are a major cause of hospital admissions in people with diabetes.
 

COVID-19 Impact

The COVID-19 storm had cast a shadow over the wound care market, disrupting healthcare services, triggering safety apprehensions among patients, leading to supply chain hiccups, constraining healthcare budgets, and diverting resources to the COVID-19 research front. Thus, the market had witnessed a dwindling number of procedures, impeding its growth trajectory.
 

Wound Care Market Trends

The increasing prevalence of acute and chronic wounds is a significant concern in healthcare with its implications on the wound care market. These wounds can result from various causes including accidents, surgeries, chronic health conditions, and lifestyle factors. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are particularly common.
 

• In the U.S., for instance, it is estimated that there are over 6 million chronic wound cases annually. Furthermore, diabetes-related foot ulcers are a prime example of chronic wounds.
   
• Additionally, growing government initiatives towards trauma cases, developing healthcare infrastructure, and patient support programs will spur the adoption of wound care, thus propelling market revenue.
   

Wound Care Market Analysis

The wound care market by product is categorized into advanced wound dressing, surgical wound care, traditional wound care, wound therapy devices and wound care biologics. The advanced wound dressing segment garnered USD 6 billion revenue size in the year 2022.
 

• The dominance of the segment can be attributed to its versatility and effectiveness in wound care. Furthermore, foam dressings are highly absorbent and can effectively manage wound exudate (fluid that oozes from a wound). They help in maintaining a moist wound environment while preventing excessive moisture buildup, which can be detrimental to wound healing.
   
• Additionally, foam dressings are soft, pliable, and cushioned, providing comfort to the patient.
   

Based on application, the wound care market is segmented into chronic and acute wounds. The chronic wounds segment is further bifurcated into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. The acute wounds are subdivided into surgical wounds, trauma wounds, and burns. This segment garnered USD 11.9 billion revenue size in the year 2022.
 

• Diabetic foot ulcers are commonly treated using moist wound dressings, which is estimated to account for USD 7.2 billion by end of 2032, because they benefit from a moist wound healing environment. These ulcers, which often occur in individuals with diabetes, can be slow to heal and prone to complications due to the underlying factors associated with diabetes.  
   
• Further, diabetic patients are at an increased risk of wound infections due to compromised immune function and poor circulation. Wound care dressings help create a barrier against external contaminants, reducing the risk of infection, thereby promoting segmental growth.
   

Based on end-use, the wound care market is segmented into hospitals, specialty clinics, home care settings, and other end-users. The hospitals segment garnered USD 8 billion revenue size in the year 2022.
 

• Hospitals have wound care teams and specialized wound care nurses that are experienced in assessing, treating, and managing various types of wounds. They are knowledgeable about the latest wound care techniques and technologies.
   
• Further, hospitals typically have a wide range of advanced wound care products, including specialized dressings, negative pressure wound therapy, and other innovative wound management tools. This ensures that the most appropriate and effective dressing can be selected for each patient's unique requirement. Thus, the aforementioned factors are estimated to augment market expansion.
   

U.S. wound care market accounted for USD 8 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• Increasing government initiatives towards diabetes care will accelerate industry expansion.
   
• For instance, National Diabetes Education Program (NDEP) is the joint effort of the National Institutes of Health and Centers for Disease Control and Prevention (CDC). National Diabetes Education Program seeks at reducing burden of prediabetes by delivering diabetes-related education to a range of people of emerging nations, faith-based organizations, ethnic minorities, community-based organizations, and healthcare providers.
   
• Furthermore, the strong focus on research and development and continuous innovation in wound care will bolster the market demand.
   

Wound Care Market Share 

The wound care industry is consolidated, with key players including, Smith & Nephew, B. Braun Melsungen AG, and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in September 2021, Omeza announced that the U.S. FDA had approved its Omeza collagen matrix. This matrix is made of hydrolyzed fish collagen and is used to treat chronic wounds such as diabetic ulcers, surgical wounds, draining wounds, and partial and full-thickness wounds. Thus, rising product approvals is projected to augment industry expansion.
 

Some of the eminent market participants operating in the wound care industry include:

• Smith & Nephew
• Mölnlycke Health Care AB
• ConvaTec Group PLC
• Ethicon (Johnson & Johnson)
• Baxter International
• URGO Medical
• Coloplast Corp.
• Medtronic
• 3M Company
• Derma Sciences Inc. (Integra LifeSciences)
• Medline Industries
• Advancis Medical
• B. Braun Melsungen AG
   

Wound Care Industry News:

• In June 2023, JeNaCell first offered the wound dressing epicite balance to the German market. This dressing is ideal for pressure ulcers, diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, and soft tissue lesions—chronic wounds with low to medium exudation. This strategic introduction aimed to diversify the company's offering and enhance revenue.
   
• In January 2023, in the U.S., Convatec introduced the ConvaFoam. ConvaFoam is a line of sophisticated foam dressings made to satisfy the needs of healthcare providers and their patients. This product launch expanded the company's product portfolio, delivering a significant competitive edge.
   

Wound care market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018 – 2032 (USD Million)

• Advanced wound dressing 
• Foam dressings
• Hydrocolloid dressings
• Film dressings
• Alginate dressings
• Hydrogel dressings
• Collagen dressings
• Other advanced dressings
• Surgical wound care 
• Sutures & staples
• Tissue adhesive and sealants
• Anti-infective dressing
• Traditional wound care 
• Medical tapes
• Cotton
• Bandages
• Gauzes
• Sponges
• Cleansing agents
• Wound therapy devices 
• Negative pressure wound therapy
• Oxygen and hyperbaric oxygen equipment
• Electric stimulation devices
• Pressure relief devices
• Other wound therapy devices
• Wound care biologics 
• Skin substitutes
• Biological
  • Allograft
  • Xenograft
  • Other biologicals
• Synthetic 
•  Topical agents

By Application, 2018 – 2032 (USD Million)

• Chronic wounds 
• Diabetic foot ulcers
• Pressure ulcers
• Venous leg ulcers
• Other chronic wounds 
• Acute wounds
• Surgical wounds
• Traumatic wounds
• Burns

By End-use, 2018 – 2032 (USD Million)

• Hospitals
• Specialty clinics
• Home care settings
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Czech Republic
  • The Netherlands
  • Denmark
  • Hungary
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa